Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease
- PMID: 20635441
- PMCID: PMC2908873
- DOI: 10.3349/ymj.2010.51.5.676
Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease
Abstract
Purpose: Metabolic syndrome (MS) has been reported as a potential risk factor of coronary artery disease (CAD). The aims of this study were to assess whether there was a relationship between MS score and CAD angiographic severity, and to assess the predictive value of individual components of MS for CAD.
Materials and methods: We retrospectively enrolled 632 patients who underwent coronary angiography for suspected CAD (394 men, 61.0 +/- 10.6 years of age). MS was defined by the National Cholesterol Education Program criteria with the waist criterion modified into a body mass index (BMI) of more than 25 kg/m(2). The MS score defined as the number of MS components. CAD was defined as > 50% luminal diameter stenosis of at least one major epicardial coronary artery. CAD angiographic severity was evaluated with a Gensini scoring system.
Results: Of the patients, 497 (78.6%) had CAD and 283 (44.8%) were diagnosed with MS. The MS score was significantly related to the Gensini score. High fasting blood glucose (FBG) was the only predictive factor for CAD. A cluster including high FBG, high blood pressure (BP), and low high-density lipoprotein cholesterol (HDL-C) showed the highest CAD risk.
Conclusion: The MS score correlates with the angiographic severity of CAD. The predictive ability of MS for CAD was carried almost completely by high FBG, and individual traits with high BP and low HDLC may act synergistically as risk factors for CAD.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures


Similar articles
-
Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease.Chin Med J (Engl). 2017 Mar 20;130(6):669-677. doi: 10.4103/0366-6999.201611. Chin Med J (Engl). 2017. PMID: 28303849 Free PMC article.
-
Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines.Cardiovasc Diabetol. 2013 Oct 2;12:140. doi: 10.1186/1475-2840-12-140. Cardiovasc Diabetol. 2013. PMID: 24088407 Free PMC article.
-
Metabolic Syndrome, Independent Predictor for Coronary Artery Disease.Clin Lab. 2015;61(10):1545-52. doi: 10.7754/clin.lab.2015.150219. Clin Lab. 2015. PMID: 26642718
-
Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.Am J Cardiol. 2004 Jan 15;93(2):159-64. doi: 10.1016/j.amjcard.2003.09.032. Am J Cardiol. 2004. PMID: 14715340
-
Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease.Int J Clin Pract. 2008 May;62(5):717-22. doi: 10.1111/j.1742-1241.2008.01702.x. Epub 2008 Feb 7. Int J Clin Pract. 2008. PMID: 18266712
Cited by
-
Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population.J Korean Med Sci. 2011 Jul;26(7):900-5. doi: 10.3346/jkms.2011.26.7.900. Epub 2011 Jun 20. J Korean Med Sci. 2011. PMID: 21738343 Free PMC article.
-
Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease.Chin Med J (Engl). 2017 Mar 20;130(6):669-677. doi: 10.4103/0366-6999.201611. Chin Med J (Engl). 2017. PMID: 28303849 Free PMC article.
-
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?Vascul Pharmacol. 2012 Nov-Dec;57(5-6):179-86. doi: 10.1016/j.vph.2012.02.001. Epub 2012 Feb 9. Vascul Pharmacol. 2012. PMID: 22342811 Free PMC article. Review.
-
Subclinical left ventricular systolic dysfunction in patients with metabolic syndrome: A case-control study using two-dimensional speckle tracking echocardiography.ARYA Atheroscler. 2016 Nov;12(6):254-258. ARYA Atheroscler. 2016. PMID: 28607564 Free PMC article.
-
Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines.Cardiovasc Diabetol. 2013 Oct 2;12:140. doi: 10.1186/1475-2840-12-140. Cardiovasc Diabetol. 2013. PMID: 24088407 Free PMC article.
References
-
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. - PubMed
-
- James PT, Rigby N, Leach R International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3–8. - PubMed
-
- Jørgensen ME, Borch-Johnsen K. The metabolic syndrome--is one global definition possible? Diabet Med. 2004;21:1064–1065. - PubMed
-
- Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–1778. - PubMed
-
- Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812–819. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous